Guggenheim cuts Nike stock price target to $60 on retail outlook

Nike shares face a cautious setup despite a fiscal Q4 beat: adjusted EPS of $0.20 vs $0.12 expected and revenue of $11.0B vs $10.85B, helped partly by a one-time tariff recovery. Guggenheim cut its price target to $60 from $74 (kept Buy) citing reduced retail multiples and “noise,” while management guided first-quarter sales down low-to-mid single digits and flagged a mid-April slowdown. Shares still trade around $41.05 (down 49% from the $80.17 52-week high), with investors reacting to the conservative sales outlook rather than the earnings upside.

Analysis

The market is likely over-penalizing the top-line caution and underweighting the margin signal. If gross margin improves earlier than expected, the earnings trough can arrive before revenue inflects, which matters because the stock is already discounting a recessionary multiple on a business that still has North America growth and brand pricing power. That setup usually favors a sharp bear-market rally in the next 4-8 weeks if channel checks stop deteriorating.

Winners/losers: NKE’s weaker sell-through and reset cadence typically pressures wholesale partners with high athletic exposure in the near term, but it can also create a temporary inventory vacuum that benefits rivals with fresher assortments and less promo intensity. SKX and ASO can take shelf-share at the margin, while broad retail proxies like XRT may see mixed effects: better traffic from promotions, worse gross margin dollars from heavier discounting. On the supply-chain side, softer China/EMEA orders can ripple back to Asian manufacturing and freight volumes, but that is a months-long effect, not an immediate P&L issue.

The key falsifier is whether gross margin expansion is truly the start of stabilization or just a tariff/one-time mix benefit. If Q1 guidance still tracks low-to-mid single-digit declines into the back-to-school order window, the name likely remains a value trap and the multiple can compress further despite the lower target. Conversely, a flat-to-up North America comp and any upward revision to FY gross margin would force estimates higher quickly.

The consensus is missing that this is a quality-vs-visibility debate, not simply a growth miss: when a branded consumer staple gets priced like a cyclical retailer, the asymmetry shifts to any operating lever that can defend EPS. A new CFO and Analyst Day matter because they can reset the narrative from 'demand decay' to 'margin rebuild,' and that can happen before sales reaccelerate. For 6-18 months, the real question is whether China is a permanent share loss or just a deferred replacement cycle; that determines whether this is a trough multiple or a long-duration de-rating.

Key Decisions for Investors

• Tactically long NKE for a 4-8 week mean-reversion trade if the stock can hold the low-$40s; risk/reward improves if gross margin commentary remains intact, with a falsifier on any Q1 guide cut beyond low-to-mid single digits.
• Pair trade: long NKE / short XRT or SKX into the next earnings cycle to express a stabilization-in-margins view while hedging broad retail beta; this works best if the next read-through is more about inventory normalization than outright demand rebound.
• If you want convexity, buy NKE call spreads targeting the November Analyst Day window; the trade is for a narrative reset, not immediate sales acceleration, and should be stopped if North America comp trends roll over again.
• Avoid adding to TGT on the idea of cheap apparel traffic spillover; weaker Nike sell-through usually means more promo pressure and less margin quality for apparel/footwear-heavy retailers over the next 1-2 quarters.